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The relationship between protein synthesis, folding, and
disulfide formation within the endoplasmic reticulum (ER) is
poorly understood. Previous studies have suggested that pre-
existing disulfide links are absolutely required to allow protein
folding and, conversely, that protein folding occurs prior to
disulfide formation. To address the question of what happens
first within the ER, that is, protein folding or disulfide forma-
tion, we studied folding events at the early stages of polypeptide
chain translocation into the mammalian ER using stalled trans-
lation intermediates. Our results demonstrate that polypeptide
folding can occur without complete domain translocation. Pro-
tein disulfide isomerase (PDI) interacts with these early inter-
mediates, but disulfide formation does not occur unless the
entire sequence of the protein domain is translocated. This is
the first evidence that folding of the polypeptide chain precedes
disulfide formation within a cellular context and highlights key
differences between protein folding in the ER and refolding of
purified proteins.
Intramolecular disulfide bonds are a common feature of
secretory proteins that can be crucial to structure, stability, and
function (1). Disulfide bond formation requires the free thiol
groups of two cysteine residues to be positioned in a correct
steric conformation to enable thiol-disulfide exchange to occur
with an accessible catalyst (2). This precise alignment of often
widely separated cysteines is highly dependent on polypeptide
chain folding. Once formed, disulfide bonds can influence fur-
ther folding by constraining the polypeptide and restricting the
number of possible folding conformations (3). Therefore, the
process of disulfide formation is intimately coupled with fold-
ing (4), and the rules and mechanisms dictating this process
remain a central question in protein folding research.
In the eukaryotic cell, proteins are synthesized on cytosolic
ribosomes at a rate of 1–5 amino acids per second (5). This
time span enables folding to occur in partially synthesized
intermediates, before chain release. If a protein contains a sig-
nal sequence then it is targeted to the secretory pathway, where
the extending nascent chain is extruded through the Sec
translocon and into the endoplasmic reticulum (ER)2 (6). Here
post-translational modifications, including signal peptide
cleavage and glycosylation, can take place.During translocation
the spatial restrictions within both the ribosome and Sec com-
plex limit folding to chain compaction and formation of simple
tertiary structure (7, 8). As the nascent chain emerges into the
ER lumen, the increased space available allows for more com-
plex structure formation (9, 10). In contrast to the cytosol, the
ER environment is specialized for disulfide formation and rear-
rangements, with a carefully regulated redox balance to enable
both oxidation and reduction of disulfides (11). These reactions
are catalyzed by ER-resident protein disulfide isomerase (PDI)
family members through the process of thiol-disulfide ex-
change (12). Although disulfide formation commonly occurs
after chain release, it can occur in a growing chain, from the
point where the second of two paired cysteine residues enter
the ER (13). Despite experimental identification of intrachain
disulfides in translation intermediates (14, 15), the relationship
between the formation of disulfides and the processes of trans-
location and folding remains unclear.
In this study our aim was to characterize at what stage intra-
chain disulfides form in relation to polypeptide translocation,
folding, and interactions with PDI. We designed a protein con-
struct consisting of 2-microglobulin (2M) with a C-terminal
extension. 2M is a small (11 kDa) secreted protein that forms
an immunoglobulin fold and contains a single intramolecular
disulfide between its only two cysteine residues (16). The exten-
sion enables disulfide formation at the ER exposed N terminus,
whereas the C terminus remains attached to the ribosome.
This protein is expressed through in vitro translation reac-
tions to generate stalled intermediates that are representa-
tive of the different stages of polypeptide translocation, pro-
viding insight into the early stages of protein compaction
and disulfide formation.
Results
Experimental design
To provide a suitable substrate to study early folding events
and disulfide formation using stalled translation intermediates,
we added aC-terminal polypeptide extension onto human2M
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(Fig. 1,A and B). This extension ensures that the 2M sequence
will be fully translocated across the ER membrane whereas the
polypeptide chain will still be attached to the ribosome (Fig.
1C). The extension provides an inert linker that should form a
uniform extended structure between the folding domain and
the ribosome, allowing control of ER exposure and clear inter-
pretation of folding at the N terminus. Between 2M and the
extension we engineered a glycosylation site (NST) to monitor
translocation, a V5 epitope for immunoprecipitation, and a
string of methionine residues (Met5) to boost the signal of the
radiolabeled translation product.
The plasmid encoding extended 2M was used as PCR tem-
plate for production of linear DNA fragments which were sub-
sequently transcribed into RNA. The RNA was then used to
program rabbit reticulocyte lysate translation reactions con-
taining ER-derived dog pancreas microsomes (DPMs) or semi-
permeabilized cells (SP cells). The rabbit reticulocyte lysate
does not contain added DTT and is, therefore, an appropriate
system to study disulfide formation (17). Appropriate reverse
primer design for the PCR (supplemental Table S3) enables
linear DNA of any length to be produced so that the translation
product can be controlled to the length of a single amino acid.
Omitting a stop codon from the reverse primer generates tem-
plates encoding stalled translation intermediates. This system
can be used to generate radiolabeled intermediates of any
length to assess folding status and disulfide formation at
defined stages of translocation. In addition to these stalled
intermediates, we also generate transcripts that contain a stop
codon to initiate release from the ribosome. We refer to the
constructs without stop codons as stalled intermediates and
those with stop codons as released.
Glycosylation reveals the intermediate length required for full
translocation of the globular domain
To determine how folding events are coordinated in our
stalled intermediates, we first estimated the chain length
required to achieve full ER exposure of the 2M domain. The
catalytic site of the oligosaccharide transferase complex (OST)
is located on the luminal side of the ER membrane; therefore
glycosylation (at position 120) is a useful assay for translocation.
Stalled translation intermediates were purified by immunoiso-
lation using a 2M-specific antibody and analyzed by reducing
SDS-PAGE and autoradiography. In the absence of DPMs each
translation product is present as a single band, which repre-
sents the unprocessed pre-protein (Fig. 2A). On addition of
DPMs, targeting and translocation resulted in cleavage of the
20-amino acid signal peptide to produce the mature protein,
which is detected at all chain lengths (Fig. 2B, asterisk). Glyco-
sylation results in a band that runs higher than the translation
product on SDS-PAGEand is present for intermediates 195 and
longer (Fig. 2B). Therefore, we can estimate that it takes 75
amino acids (195minus 120) to span the distance from theP site
of the ribosome to the active site of the OST. It is known that it
takes 12–14 residues of an extended peptide to reach the active
site of the OST from the ER side of the membrane (18); there-
fore, we can estimate that it takes63 amino acids from the P
site of the ribosome before exposure to the ER lumen (Fig. 2D).
Treatment with RNase A releases the translation product,
improving the efficiency of signal peptide cleavage and expos-
ing the glycosylation site, so that glycosylation is detected at all
chain lengths (Fig. 2C). Importantly these results also demon-
Figure 1. Primary structure of the extended 2M construct and antici-
pated folding during translocation. A, schematic representation of 2M
with and without the extension showing the cysteine residues (Cys-45 and
Cys-100) and the organization of key elements including the glycosylation
site (NST), V5 epitope (V5), and methionine residues (Met5). B, the complete
amino acid sequence of the extended 2M construct with the 2M domain
highlighted ingreen, the additional elements (NST, V5, andMet5) inwhite, and
the extension in gray. C, model of the ribosome-Sec complex displaying the
extended 2M construct. The N-terminal 2M domain folds to the native
structure once ER exposed, whereas the C terminus is attached to the cytoso-
lic ribosome. 5xM, Met5; aa, amino acid.
Figure 2. Translation and translocation of extended2M intermediates.
Autoradiographs of radiolabeled, immunoisolated translation product gen-
erated from stalled intermediates of between 165 and 220 amino acids. Gels
were rununder reducing conditions.A and B, translationswere performed (A)
in the absence of DPMs and (B) in the presence of DPMs. An example of signal
peptide cleavage (*) and glycosylation (arrow) are highlighted for the 220
sample.C, the translationwasperformed in thepresenceofDPMsand treated
with RNase A on completion. These data are representative of three indepen-
dent repeats. D, model showing the approximate extension length required
to span the ribosome-Sec complex as estimated from the glycosylation data.
Protein folding and disulfide formation
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strate that the stalled translation intermediates are stably
attached to the ribosome, as no glycosylation of intermediates
of less than 190 amino acids occurs in the absence of added
RNase.
Disulfide formation only occurs once the full folding domain is
exposed in the ER lumen
The next step was to determine whether disulfide formation
occurs in the stalled, ER-exposed translation intermediates. To
assay disulfide formation we froze the disulfide status, on com-
pletion of translation, using an alkylating agent and compared
nonreduced and reduced forms of the same samples on SDS-
PAGE. To ensure that the single disulfide bond causes a detect-
able change in gel mobility, we first tested native released 2M
(stop codon at position 120). In the absence of DPMs the pre-
protein runs as a single band under both reducing and nonre-
duced conditions (Fig. 3A), demonstrating a lack of disulfide
formation before targeting. On addition of DPMs the signal
peptide is cleaved to produce the mature protein, which has a
greater mobility (arrow) under nonreducing conditions indi-
cating a disulfide. This change in mobility is absent from a
mutant 2M (C45A), which contains a single cysteine residue
and is, therefore, incapable of disulfide formation.
To assess disulfide formation in the extended 2M transla-
tion intermediates, we used a construct that does not contain a
glycosylation site (2M-extension AST) (supplemental Table
S1) to simplify changes in electrophoretic mobility. According
to the translocation data, 63 residues of the extension se-
quence are required to span the ribosome-Sec complex (Fig.
2D); therefore, the second of the two cysteine residues (position
100) is expected to enter the ER at an intermediate length of
165 residues, and disulfide formation could occur from this
point onwards. Stalled intermediates were generated between
165 and 205 amino acids in length (Fig. 3B). At intermediate
lengths between 165 and 185, the nonreduced samples do not
shift in relation to the reduced samples (Fig. 3B, lanes 1–6)
indicating an absence of disulfide formation. At intermediate
lengths of 190 and 205 the presence of faster migrating species
were detected in the nonreduced samples (lanes 7–10), reveal-
ing disulfide formation in these longer intermediates. Disulfide
formation was also detected in the pre-protein as a band that
runs between the pre-protein and mature protein. This indi-
cates that disulfide formation can take place before signal pep-
tide cleavage. The intermediate length required for disulfide
formation (190 amino acids), coincides with the approximate
ER exposure of the entire 2M sequence, which is 20 amino
acids after the second of the two cysteine residues emerges.
Therefore, despite both cysteine residues being exposed, disul-
fide formation does not occur until the whole of the 2M
sequence is ER exposed.
PDI interactions take place before disulfide formation
PDI is a highly abundant, ER-resident protein that catalyzes
the process of disulfide formation (19) and can interact with
nascent chains (20, 21). We used a cross-linking approach to
determine whether PDI noncovalently interacts with extended
2M intermediates. For this purpose we added a cysteine-spe-
cific cross-linking agent (bismaleimidohexane) to stalled trans-
lation intermediates (2M-extension AST) and then immuno-
isolated with a PDI antibody. Cross-linked complexes were
detected between PDI and intermediates beginning at 145
amino acids (Fig. 3C) (a length at which we expect ER nascent
chain exposure of80 amino acids) and at all longer interme-
diate lengths.No cross-linkingwas seen to the 119 intermediate
despite the availability of the first cysteine within the ER for
Figure 3. Intrachain disulfide formation and PDI interactions. Disulfide
formation is assessed by SDS-PAGE analysis of immunoisolated, radiolabeled
translation product under reducing (DTT) and nonreducing (DTT) gel
conditions. A, autoradiographs show results for released,2M (Wt, wild-type)
and the single cysteinemutant (C45A) in the absence and presence of DPMs,
with pre-protein (*) andmature protein (**) highlighted. Under nonreducing
conditions oxidized 2MWt is detected by a shift in the mature protein
(arrow). B, autoradiographs of stalled, extended 2M intermediates between
165 and 205 amino acids translated in the presence of DPMs. Molecular
weight markers represent 17 (black) and 25 (gray). Arrows indicate the shift
associatedwith disulfide formation for the 190 and 205 stalled intermediates
under nonreducing conditions. Results shown are representative of five
repeats (165–190 samples) and three repeats (205 sample).C, PDI interactions
aredetected throughcysteine-specific cross-linking, followedby immunoiso-
lation using a PDI antibody. Autoradiograph of a reducing gel shows a
range of stalled intermediates (aa 119–220) with PDI-specific cross-links
detected for intermediates from 141–220 (PDI XL). PDI expressed in the
translation from endogenous RNA was also immunoisolated (PDI). The
same samples were immunoisolated with an ERp57 antibody and no
cross-links were detected. Data are representative of three independent
repeats. D, diagram summarizing the timing of disulfide formation and
PDI interactions relative to the entry of 2M into the ER. The arrow indi-
cates the C-terminal end of the 2M sequence (position 120) and the
asterisk shows the Sec-ER boundary.
Protein folding and disulfide formation
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cross-linking. The cross-linked products increase in size,
reflecting the increase in length of the translation intermedi-
ates. Endogenous PDI translated and radiolabeled during the
reactions was also detected by immunoisolation. PDI runs as
two distinct bands, which reflect alternate conformations of the
protein that are covalently stabilized by cross-linking, as
reported previously (22). These bands are easily distinguished
fromcross-linkedproducts as theymigrate to the samedistance
in each sample (Fig. 3C). Control samples show no interaction
with the PDI family member ERp57, which usually recognizes
glycosylated substrates (23), demonstrating that the cross-
linked products are specific to PDI. Endogenous radiolabeled
ERp57 is absent probably because of a lower level of translation
of the endogenous mRNA compared with PDI. The length of
intermediates interacting with PDI indicates that it recognizes
stalled intermediates where the second cysteine is not exposed
to the ER lumen, i.e. before disulfide bond formation is possible
(Fig. 3D).
Refolding of2M requires the disulfide bond
In the next set of experiments we describe folding status of a
polypeptide chain. For clarity we refer to folding status, which
reflects the extent towhich the polypeptide has formed second-
ary and tertiary structures on its pathway to the native state.We
also refer to compaction to reflect an ensemble of early folding
intermediates that have undergone hydrophobic collapse.
To evaluate the folding status of translocation intermediates
we need a technique that can discriminate between unfolded
and compact polypeptides. This can be done using protease
susceptibility, in which typically the peptide backbone becomes
protease protected on folding. To assess how protease resis-
tance relates to the folding status of 2M, we investigated the
refolding of purified recombinant protein (residues 21–119)
following denaturation in urea (Fig. 4A). At high urea concen-
trations (6–7.5M) the protein is highly susceptible to digestion.
As the urea concentrations decrease the protein folds and we
see the appearance of protease-resistant 2M.When the bands
are quantified and plotted (Fig. 4B), the resulting refolding
curve follows a cooperative two-state process with a midpoint
of denaturation at 4.5 M urea. When the assay is repeated
under reducing conditions the protein is protease susceptible
even at low urea concentrations (2–5M), indicating a failure to
refold. At higher urea concentrations there is some undigested
protein, which can be attributed to loss of thermolysin activity
in high concentrations of urea and reducing agent. These
agents destabilize thermolysin structure and cause reduction of
catalytically and structurally important metal ions, which
therefore results in loss of activity. Overall these experiments
highlight the strict requirement for the disulfide to allow refold-
ing of purified 2M from denaturant, a finding that agrees with
previous studies (24).
Wenextadapted theproteolysis assay toassessprotease resis-
tance of 2M produced in the translation system. Saponin was
added following completion of translation to permeabilize the
membranes and allow thermolysin access to the ER lumen.We
repeated the denaturant refolding experiment, comparing pro-
tease susceptibility of released (stop codon included at position
Figure4.Thedisulfidebond isnot required for foldingduringnativesynthesisbut stabilizes the final fold.A, CoomassieBlue stainedSDS-PAGEshowing
proteolysis of purified2M (21–119) (*) by thermolysin (arrow) across a rangeof urea concentrations, under nonreducing and reducing conditions. B, refolding
curves of reduced (circles) andoxidized (squares)2Mproducedbyquantificationof gel bands following treatment (mean S.D. forn 3).C, autoradiographs
of thermolysin-induced proteolysis of refolded, released 2M (Wt) compared with the single cysteine mutant (C45A), produced through in vitro translation in
thepresence ofDPMs. Data are representative of four independent experiments.D, schematic representation of2Mshowing the location of the destabilizing
mutations relative to the cysteine residues. E, proteolysis time courses of released2MWt (squares),2MC45A (circles), and2M3M (triangles) produced through
in vitro translation in the presence of DPMs. The inset shows representative autoradiographs of these time courses with the plot showing degradation of the
mature protein (*) calculated from gel quantification of mature protein and subsequent normalization to total protein (pre-protein plus mature protein)
(mean S.D. for n 3). F, thermolysin (TLN) digestion of nondenatured, released 2M translation product (Wt, C45A, or 3M) synthesized in the absence of
DPMs. Image is representative of two independent experiments.G, PDI interactions detected by cross-linking toWt or the 3Mmutant, ()no template. Data
are representative of three independent experiments. All gels in this figure were run under reducing conditions. Trend lines in panels B and E are for guidance
only.
Protein folding and disulfide formation
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120) 2M or the C45A mutant (Fig. 4C). The mature protein
refolded as evidenced by the presence of resistance bands
across the range of urea concentrations. However, the C45A
mutantfailedtorefold(noresistance),reflectingthesamedepen-
dence on the disulfide bond as observed for purified 2M.
Undigested protein is observed at high urea concentrations in
both samples because of loss of thermolysin activity under these
conditions.
The disulfide bond is not required for protease resistance when
2M is synthesized in the translation system
To characterize the folding status of stalled translation inter-
mediates requires proteolysis experiments in the absence of
denaturant. Therefore, we needed an alternative control to rep-
resent the unfolded state of the protein. For this purpose we
introduced three mutations (V29A, V57A, and F90A) (Fig. 4D)
that are known to destabilize 2M (25) and compared the pro-
tease susceptibility of this triple mutant (3M) to the wild-type
protein with a proteolysis time course. For these experiments
we translated the released form of 2M (stop codon at position
120) in the presence of DPMs (Fig. 4E). For the wild-type pro-
tein there was a decrease in the amount of pre-protein and an
increase in the amount of mature protein following protease
digestion. Quantification of the mature protein (Fig. 4E, plot)
shows that it remains stable over the 10-min time course, dem-
onstrating the protease resistance of released wild-type 2M.
The destabilizing mutations (3M) make both the pre-protein
and the mature protein more protease susceptible, with both
rapidly degraded on thermolysin treatment (Fig. 4E, plot and
inset). When we tested the C45A mutant in the same assay
(Fig. 4E), we expected the digestion profile to resemble the
3M mutant, because of the requirement for the disulfide for
denaturant refolding. However, its protease sensitivity more
closely resembled the wild-type protein. This result indicates a
difference in folding status between the polypeptide synthe-
sized in microsomes and that formed following refolding from
denaturant.
Protease resistance can also be conferred by interactions
with cellular proteins such as PDI. To investigate this possibility
we assessed proteolytic digestion of translation products syn-
thesized in the absence of DPMs and, therefore, PDI.We found
the wild-type protein and the C45A mutant to be protease
resistant but the 3Mmutant to be protease susceptible (Fig. 4F).
Proteins from the reticulocyte lysate could protect the nascent
chain but it is highly unlikely that this would be selective for the
wild-type protein and C45A mutant but not the 3M mutant.
We also determined whether PDI binds to the 3M mutant. If
resistance to proteolysiswasmerely a consequence of PDI bind-
ing then we would predict that PDI does not bind to the 3M
mutant. We chose a construct of 205 amino acids as wild-type
intermediates of similar length associated with PDI (Fig. 3C).
We found that thewild-type construct aswell as the 3Mmutant
cross-linked to PDI (Fig. 4G). Hence, binding of the 3M poly-
peptide to PDI does not protect the nascent chain from prote-
olysis. Therefore, these results support our interpretation that
the protease resistance is conferred by folding.
Compaction of the nascent chain occurs in intermediates
partially exposed to the ER lumen
To assess protease resistance of the extended 2M interme-
diates we used SP cells derived from the human fibrosarcoma
cell line HT1080 as an ER source, instead of DPMs. We
switched to this system because it has been shown to result in
more efficient folding of proteins in more native conditions,
because of the presence of an intact ER (17). To confirm that
translocation and disulfide formationwere consistent with data
gathered using DPMs, both the glycosylation and the oxidation
experiments were repeated with similar results (supplemental
Fig. S2). The only difference was the absence of disulfide for-
mation in the pre-protein, suggestingmore efficient signal pep-
tide cleavage in the SP cell system.We also carried out transla-
tion under conditions that only labeled cysteine. This ensured
an equal labeling of protease-resistant products as only the
2M coding region contains cysteine.
Stalled translation intermediates (2M-extension AST 141–
205) were assessed for protease susceptibility to determine
their folding status (Fig. 5A). For each intermediate length
tested, translation products remained after digestion, indicat-
ing that partially exposed intermediates compact to form pro-
tease-resistant conformations. This result with stalled interme-
diates inwhich the2Mdomain is only partially exposed shows
that compaction occurs before the second of the two cysteine
residues is present in the ER lumen. Hence, the acquisition of
protease resistance is independent of disulfide formation.
When the length of the intermediate reaches 190, two promi-
nent lower molecular weight bands are present (Fig. 5, arrows).
This is the length at which the extension becomes ER exposed,
indicating that protease susceptibility in this region causes
release of protease-resistant2M fragments (confirmed by fur-
ther biochemical analysis (supplemental Fig. S3)). When the
same experiment was repeated with the 3M mutant, all inter-
Figure5. Co-translational foldingof extended2Mtoprotease resistant
conformations proceeds as the nascent chain emerges. Autoradiographs
showing stalled translation intermediates of extended 2M produced in the
presence of SP cells, assessed for protease susceptibility by thermolysin (TLN)
treatment. A and B, digestion profiles of translation intermediates between
(A) 141–205 and (B) 119–220 amino acids in length, for wild-type (Wt), 3M
mutant (3M) and the single cysteine mutant (C45A). Arrows indicate lower
molecular weight resistant bands and the asterisk highlights an example
of undigested material for the 205 intermediate. The gels were run under
reducing conditions and are representative of three or more independent
experiments.
Protein folding and disulfide formation
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mediates were completely digested, validating our interpreta-
tion that protease resistance reflects the folding status of the
nascent chain.
Protease resistance was observed for the shortest stalled
intermediate length (141), which has78 residues of pre-pro-
tein exposed. To determine whether protease resistance occurs
at even shorter stalled intermediates, we tested the 119 inter-
mediate, in comparison to the 175 and 220 intermediates (Fig.
5B). We also included the C45A mutant to confirm our previ-
ous assumption that compaction occurs in the absence of a
disulfide. A degree of resistance was detected in the shorter
intermediate 119, indicating that compaction is occurring upon
exposure of as few as 36 amino acids (119  63  20) of the
mature sequence to the ER lumen. The C45Amutants gave rise
to a similar digestion profile to that of the wild-type protein,
confirming that the disulfide is not required for this initial com-
paction. All the 3Mmutant intermediates tested were sensitive
to protease digestion.
Taken together these proteolysis assays demonstrate that
even short translation intermediates have protease resistance
upon exposure to the ER lumen. This resistance indicates that
nascent chain compaction can occur once sufficient polypep-
tide is exposed to the ER lumen (as long as there is time to do
so), confirming that some folding occurs long before disulfide
formation is possible. The complete sensitivity of the folding
defective mutant validates the results with the wild-type
sequence.
Discussion
Previous efforts to evaluate the early stages of nascent chain
folding have measured folding by either FRET- or NMR-based
approaches and have used prokaryotic translation systems
(26–28). The results from these studies have shown that folding
can occur co-translationally with evidence of compact struc-
tures being formed by association with the ribosome. In this
study we evaluated folding by the acquisition of protease resis-
tance and crucially focused on events at the ER translocon. We
showed that collapse of a polypeptide to a protease-resistant
state occurred following exposure of less than 40 amino acids of
the mature sequence to the ER lumen. Strikingly, a mutant
polypeptide that is unable to reach the final native structure
does not form the same protease-resistant state. Importantly,
we have been able to demonstrate that the single disulfide does
not form until the whole of the protein domain is translocated.
In addition and in contrast to protein refolding, the disulfide is
not required for compaction of the polypeptide chain to a pro-
tease-resistant state within the cellular milieu.
Previously, it has been shown that protein activity is achieved
soon after the functional domain becomes exposed (10), requir-
ing the full sequence to enter the ER lumen. In our system,
compaction is observed with partial ER exposure, but disulfide
formation, indicating fold completion, is delayed until 2M is
fully exposed. These results suggest that formation of collapsed,
protected conformations progresses incrementally as the nas-
cent chain is extruded into the ER lumen but that the final
native structure requires the entire 2M sequence to be avail-
able. This incremental progression parallels co-translational
folding on prokaryotic ribosomes, in which compaction is
observed within the vestibule of the ribosome, before native
folding occurs on domain exposure (26). In other examples nas-
cent chains remain completely unstructured until the full
domain is exposed (29), some not achieving their fold until the
domain is far past the ribosome (27).
On ER entry the nascent chain is exposed to resident folding
factors including the disulfide catalyst PDI. This enzyme has
been shown to interact with nascent chains directly to form
intermolecular disulfides that are later resolved on disulfide
formation (20). Our study provides insight into this interaction
demonstrating PDI binding when the domain is partially ER
exposed, before disulfide formation is possible. This result sup-
ports a previous study showing that PDI recognizes partially
folded intermediates and remains bound throughout the fold-
ing process (30). Despite PDI binding at early stages, disulfide
formation is delayed until the full 2M sequence is exposed,
suggesting that the full sequence is required to form the tertiary
structure to accurately position cysteines. The idea that folding
drives disulfide formation is emerging as a common mecha-
nism in proteins and is supported by findings from molecular
dynamic simulations (31) and single molecule atomic force
microscopy experiments (32), which both show that compac-
tion and folding of the polypeptide chain precedes disulfide
formation.
Our results also shed light on the function of the 2M disul-
fide bond, which is a highly conserved feature of the immuno-
globulin fold (33). It has been established that the2Mdisulfide
is required for successful refolding from denaturant (24, 34),
however, our results here indicate that this does not reflect
folding in vivo, where the vectorial nature of protein synthesis
and cellular environment allow compaction before disulfide
formation. The results suggest that the role of the disulfide is to
stabilize the folded state rather than initiate the attainment of
the fold. This conclusion is supported by the finding that fold-
ing of immunoglobulin domains without disulfides can be
restored through stabilizing mutations (35) and, although rare,
functional immunoglobulin domains can exist without disul-
fides (36).
The model protein for this study was chosen because of its
single domain and disulfide but it is also representative of the
immunoglobulin family, which is often a modular component
of large proteins, such as antibody chains. In such examples,
domain exposure and opportunities for folding often occur
before ribosome release. Therefore, the folding events de-
tk;1scribed for the extended 2M construct are representa-
tive of immunoglobulin domains. Although the secreted
proteins are diverse, mechanisms of co-translational oxida-
tive folding are likely to share common features and, there-
fore, our results with this simplified experimental system are
likely to be applicable to other single domain proteins with
more complex disulfides. A bigger challenge will be to deter-
mine when native disulfide formation occurs between differ-
ent protein domains in multidomain proteins such as the low
density lipoprotein receptor (37). In this case, acquisition of
the final native structure occurs post-translationally; non-
native disulfides form prior to correct folding and are an
obligatory requirement for correct folding. Our results go
some way to address initial folding events but many ques-
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tions remain to be answered before we obtain a clear picture
of how proteins fold in the complex environment of the ER.
Experimental procedures
Molecular graphics
2M (Fig. 1) was drawn using PDB file 1A1Musing theUCSF
Chimera package from the Resource for Biocomputing, Visual-
ization, and Informatics at the University of California, San
Francisco (38).
Template generation
The2M-extension constructwas codonoptimized and syn-
thesized as plasmid DNA using GeneArtTM gene synthesis
(ThermoFisher Scientific) (DNA sequence, supplemental Fig.
S1). Mutations were introduced by site-directed mutagenesis
using appropriate primer pairs and ACCUZYMETM (Bioline).
The original plasmids or associated mutants (supplemental
Table S1) were used as a template for PCR using a forward
primer containing the T7 promoter, Kozak consensus se-
quence, and start of the 2M sequence (2M-extension Fwd,
supplemental Table S2). For stalled substrates we used various
reverse primers that complement sequences corresponding to
the extension region of the protein and that lack a stop codon
(supplemental Table S3). Substrates that were released were
produced using a reverse primer that contained a stop codon
(supplemental Table S3). PCR products were ethanol precipi-
tated, resuspended in nuclease-free water, and transcribed into
RNA templates using T7 RNA polymerase (37 °C, 2 h) as
described (23). The resulting RNA was also ethanol precipi-
tated and suspended in nuclease-free water for use as template
in translation reactions.
Cell-free translation
DPMs were isolated from canine pancreas as described pre-
viously (39), snap-frozen, and stored at 80 °C. SP HT1080
human fibrosarcoma cells were prepared as described previ-
ously (17), and cells were added to a concentration of105 per
25 l translation. Translations were performed using the Flexi®
Rabbit Reticulocyte Lysate System (Promega) containing
amino acids minus methionine (20 M), KCl (40 mM), glucose-
6-P (5mM) and radiolabeledwith EasyTagTMEXPRESS35S Pro-
tein LabelingMix (PerkinElmer) (1l/25-l reaction). Samples
were incubated at 30 °C for 10min in the absence or presence of
DPMs or SP cells to translate protein with radiolabeled methi-
onine residues. On completion samples were returned to ice
and cycloheximide (2 mM) was added followed by N-ethylma-
leimide (NEM) (20 mM). If samples required treatment with
RNase A (0.2 mg/ml, 5 min at 30 °C) then it was added before
cycloheximide/NEM. For proteolysis reactions, translation
product was labeled at cysteine residues by adding amino acids
minus Cys (in place of amino acidsminusMet) and an excess of
methionine (100M). Samples were processed through centrif-
ugation and immunoprecipitation, as detailed below, for anal-
ysis through SDS-PAGE and autoradiography.
Sample processing and immunoprecipitation
For glycosylation experiments DPM-containing samples
were centrifuged (16,000 g, 10min) to isolate themicrosomes
and remove untargeted material. For disulfide formation anal-
ysis and cross-linking experiments, the pelleted DPMs were
further washed with 150 l high-salt buffer (3 M potassium
acetate, 20 mM HEPES, pH 7.5) followed by 100 l of 20 mM
HEPES, pH 7.5, to further remove untargeted material and
improve the clarity of the data. Pellets fromcross-linking exper-
iments were resuspended directly in immunoprecipitation (IP)
buffer (50mMTris, pH7.5, 1% (v/v)TritonX-100, 150mMNaCl,
2 mM EDTA, 0.5 mM PMSF, and 0.02% (w/v) sodium azide).
Pellets from glycosylation/disulfide analysis were suspended in
50 l of SDS buffer (25 mM Tris, 200 mM glycine, 0.8% (w/v)
SDS) before addition of 0.9 ml IP buffer. For samples without
DPMs, IP buffer was added directly to the samples following
cycloheximide/NEM treatment.
In all cases the processed samples in IP buffer were incubated
with 0.5% (v/v) Protein A-Sepharose (Generon) for 30 min
(4 °C) and then centrifuged (2000  g, 5 min) to pre-clear the
samples of nonspecific precipitate. The resulting supernatant
was then incubatedwith ProteinA-Sepharose (0.5% v/v) and an
appropriate antibody at 4 °C overnight. This was the polyclonal
rabbit anti-human 2M antibody (Dako) at 1/10,000 for all
experiments except for the cross-linking experiments which
used PDI or ERp57 antibodies (at 1/1000) and experiments
using the anti-V5 antibody (Invitrogen) (used at 1/10,000),
where specified. The following day samples were isolated by
centrifugation (2000  g, 5 min) and the pellets were then
washed (three times with 1ml of IP buffer and once with 100l
of 20 mM HEPES, pH 7.5) before eluting the protein by boiling
in reducing SDS-PAGE sample buffer. To detect disulfide for-
mation, samples were eluted from beads using nonreducing
SDS-PAGE sample buffer, the samples were then split and 10
mM DTT added to the reducing sample before boiling. To
prevent diffusion of DTT between gel lanes, samples were
treated with 100 mM NEM before loading. In all translation
experiments samples were analyzed by SDS-PAGE and
autoradiography.
Cross-linking
Translations were carried out as described above but with-
out NEM treatment. Following completion the cross-linking
agent bismaleimidohexane was added to a concentration of 1
mM before incubation (10 min) on ice. The reactions were
quenched with 5 mM DTT and prepared for immunoprecipita-
tion (described above).
Denaturant refolding and proteolysis of purified protein and
translation product
Recombinant protein was expressed and purified from the
plasmid pINK as described previously (40). A 55-M stock of
purified 2Mwas prepared in 8.5 M urea and then diluted to 12
M across a range of urea concentrations (2–7.5 M) in buffer
containing 20 mM HEPES, pH 7.5, and 10 mM CaCl2. For
reduced samples DTT was added (10 mM) to the unfolded pro-
tein stock before dilution and then in all subsequent buffers
throughout the experiment. Thermolysin (5 mg/ml) in 2.5 M
NaCl was added to samples to a final concentration of 0.2
mg/ml. After 10 min at room temperature proteolysis was
quenched by the addition of 12.5 mM EDTA. Samples were
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analyzed by reducing SDS-PAGE (18% (w/v)) and stained with
colloidal Coomassie Blue. Gel bands were quantified using
ImageJ software, and normalized to undigested protein, to esti-
mate the fraction of protein protected at each urea concentra-
tion. The values were then plotted to obtain the folding transi-
tion curves.
For refolding analysis of translation product, translations
were performed in the presence of DPMs. Following cyclohex-
imide and NEM treatment, 11 l of translation product was
denatured to a final volume of 100 l in 8.5 M urea. Samples
were then diluted to a final volumeof 425l over a range of urea
concentrations (2–7.5M) containing 20mMHEPES, pH 7.5, 10
mM CaCl2, and 0.1% (w/v) saponin. Proteolysis was carried out
as described for the pure protein above but with 0.02 mg/ml
thermolysin. After quenching with EDTA (75 mM) samples
were directly resuspended in IP buffer before immunoisolation
(2M antibody) and analysis by reducing SDS-PAGE and
autoradiography.
Proteolysis of nondenatured translation product
Translations were carried out in the presence of DPMs (time
courses in Fig. 4E) or SP cells (translation intermediates in Fig.
5 and supplemental Fig. S3) as described above, unless other-
wise stated. Following cycloheximide, NEM, and saponin (0.1%
(w/v)) treatment, thermolysin (0.02 mg/ml) and CaCl2 (10 mM)
were added to initiate proteolysis. For time courses, aliquots
were removed and quenchedwith excess EDTA at specific time
points. Samples were immunoisolated and analyzed by reduc-
ing SDS-PAGE and autoradiography as described above. Bands
were quantified using ImageJ and the values normalized to total
protein (pre-protein plus mature protein) at the start of the
reaction (0min). For proteolysis analysis of intermediates, reac-
tions were split two-thirds for digestion with the remaining
one-third used as an undigested control sample for compari-
son. After 10 min, samples were quenched with EDTA, resus-
pended in IP buffer (1 ml) and immunoisolated. Proteolysis of
samples translated in the absence of DPMs or SP cells were
carried out in the same way but without saponin.
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